Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity
Objective: Fibroblast growth factor 21 (FGF21) is a peripherally-derived endocrine hormone that acts on the central nervous system (CNS) to regulate whole body energy homeostasis. Pharmacological administration of FGF21 promotes weight loss in obese animal models and human subjects with obesity. How...
Main Authors: | Kristin E. Claflin, Andrew I. Sullivan, Meghan C. Naber, Kyle H. Flippo, Donald A. Morgan, Tate J. Neff, Sharon O. Jensen-Cody, Zhiyong Zhu, Leonid V. Zingman, Kamal Rahmouni, Matthew J. Potthoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Molecular Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877822001338 |
Similar Items
-
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-06-01) -
The relationship between the level of vitamin D, leptin and FGF23 in girls and young women with polycystic ovary syndrome
by: Agnieszka Białka-Kosiec, et al.
Published: (2022-09-01) -
Leptin, Acting at Central Level, Increases FGF21 Expression in White Adipose Tissue via PPARβ/δ
by: Lorena Mazuecos, et al.
Published: (2021-04-01) -
The Relationship between Leptin, the Leptin Receptor and FGFR1 in Primary Human Breast Tumors
by: Wyatt Boothby-Shoemaker, et al.
Published: (2020-10-01) -
Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer’s Disease
by: Yu-Jung Cheng, et al.
Published: (2021-02-01)